GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $784,000 | -1.8% | 18,000 | -0.6% | 0.03% | +13.8% |
| Q4 2021 | $798,000 | +3.9% | 18,100 | -10.0% | 0.03% | -3.3% |
| Q3 2021 | $768,000 | +27.8% | 20,100 | +33.1% | 0.03% | +30.4% |
| Q2 2021 | $601,000 | +10.9% | 15,100 | -0.7% | 0.02% | 0.0% |
| Q1 2021 | $542,000 | -3.0% | 15,200 | 0.0% | 0.02% | -8.0% |
| Q4 2020 | $559,000 | -13.2% | 15,200 | -11.1% | 0.02% | -21.9% |
| Q3 2020 | $644,000 | -7.7% | 17,100 | 0.0% | 0.03% | -17.9% |
| Q2 2020 | $698,000 | +8.4% | 17,100 | +0.6% | 0.04% | -29.1% |
| Q1 2020 | $644,000 | -8.7% | 17,000 | +13.3% | 0.06% | +57.1% |
| Q4 2019 | $705,000 | +10.2% | 15,000 | 0.0% | 0.04% | -2.8% |
| Q3 2019 | $640,000 | +6.7% | 15,000 | 0.0% | 0.04% | +12.5% |
| Q2 2019 | $600,000 | -4.3% | 15,000 | 0.0% | 0.03% | -5.9% |
| Q1 2019 | $627,000 | +9.4% | 15,000 | 0.0% | 0.03% | -24.4% |
| Q4 2018 | $573,000 | -5.0% | 15,000 | 0.0% | 0.04% | +55.2% |
| Q3 2018 | $603,000 | -0.3% | 15,000 | 0.0% | 0.03% | -6.5% |
| Q2 2018 | $605,000 | +3.2% | 15,000 | 0.0% | 0.03% | -3.1% |
| Q1 2018 | $586,000 | +10.2% | 15,000 | 0.0% | 0.03% | +14.3% |
| Q4 2017 | $532,000 | -47.6% | 15,000 | -40.0% | 0.03% | -50.0% |
| Q3 2017 | $1,015,000 | -5.8% | 25,000 | 0.0% | 0.06% | -9.7% |
| Q2 2017 | $1,078,000 | +1.6% | 25,000 | -0.7% | 0.06% | -3.1% |
| Q1 2017 | $1,061,000 | +9.5% | 25,164 | 0.0% | 0.06% | +1.6% |
| Q4 2016 | $969,000 | -10.7% | 25,164 | 0.0% | 0.06% | -11.3% |
| Q3 2016 | $1,085,000 | -0.5% | 25,164 | 0.0% | 0.07% | -15.5% |
| Q2 2016 | $1,091,000 | +7.0% | 25,164 | 0.0% | 0.08% | +13.5% |
| Q1 2016 | $1,020,000 | +1.1% | 25,164 | +0.7% | 0.07% | +17.5% |
| Q4 2015 | $1,009,000 | +5.0% | 25,000 | 0.0% | 0.06% | -7.4% |
| Q3 2015 | $961,000 | +15.4% | 25,000 | +25.0% | 0.07% | +33.3% |
| Q2 2015 | $833,000 | +20.4% | 20,000 | +33.3% | 0.05% | +21.4% |
| Q1 2015 | $692,000 | +8.0% | 15,000 | 0.0% | 0.04% | +5.0% |
| Q4 2014 | $641,000 | -28.6% | 15,000 | -23.2% | 0.04% | -28.6% |
| Q3 2014 | $898,000 | -31.6% | 19,525 | -20.4% | 0.06% | -28.2% |
| Q2 2014 | $1,312,000 | -15.4% | 24,525 | -15.5% | 0.08% | -23.5% |
| Q1 2014 | $1,551,000 | +26.0% | 29,025 | +25.9% | 0.10% | +32.5% |
| Q4 2013 | $1,231,000 | -4.4% | 23,050 | -10.1% | 0.08% | -15.4% |
| Q3 2013 | $1,287,000 | -6.4% | 25,650 | -6.8% | 0.09% | -24.8% |
| Q2 2013 | $1,375,000 | – | 27,525 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |